GGrantIndex
Sort

64,565 grants matching drug discovery

MFB: Developing Next-Generation Approaches to Targeted Protein Degradation

$2,499,998
Daniel K Nomura · University Of California-Berkeley · · FY2021 · MPS

The Pediatric Brain Tumor Consortium (PBTC)

$2,498,325
James M Boyett · St. Jude Children'S Research Hospital · U01 · FY2007 · CA

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH

$2,498,155
Robert Stanley Sherwin · Yale University · UL1 · FY2010 · RR

Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces

$2,497,111
Robert A Britton · Baylor College Of Medicine · U19 · FY2024 · AI

SPORE in Ovarian Cancer

$2,496,726
Ie-Ming Shih · Johns Hopkins University · P50 · FY2024 · CA

Positioning Mason's Regional Biocontainment Laboratory for Effective Pandemic Preparedness

$2,495,244
Farhang Alem · George Mason University · UC7 · FY2023 · AI

Deciphering novel protein quality control pathways in the nuclear periphery

$2,493,523
Christian Dirk Schlieker · Yale University · DP2 · FY2011 · OD

Chemical Countermeasures Collaboration: Chemical Threats Affecting the Nervous System

$2,493,460
Office Of The Director, National Institutes Of Health · Y01 · FY2024 · OD

SPORE in Ovarian Cancer

$2,492,537
Ie-Ming Shih · Johns Hopkins University · P50 · FY2018 · CA

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

$2,492,267
David S Stephens · Emory University · UM1 · FY2020 · AI

Disease Status Drug Metabolism and New Drug Discovery

$2,490,069
Irving William Wainer · National Institute On Aging · ZIA · FY2013 · AG

SPORE in Breast Cancer

$2,489,652
Vanderbilt University · P50 · FY2004 · CA

SPORE in Breast Cancer

$2,489,652
Vanderbilt University · P50 · FY2005 · CA

Physics-Based Simulation of Biological Structures

$2,489,342
Russ Biagio Altman · Stanford University · U54 · FY2012 · GM

CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

$2,489,269
Harry Bernard Greenberg · Stanford University · UL1 · FY2010 · RR

Molecular Analysis Of Leukocyte Activation By Chemoattractants

$2,486,098
Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

NCI-Frederick Support and Technical Services

$2,480,548
Kristin Komschlies McConville · Office Of The Director, Nci · ZIC · FY2022 · CA

Discovery of natural product-based drugs from bacterial symbionts of insects

$2,479,629
Cameron Robert Currie · University Of Wisconsin-Madison · RC4 · FY2010 · GM

Microbiome Discovery and Mechanisms to Combat Antibiotic Resistance at Mucosal Surfaces

$2,479,201
Robert A Britton · Baylor College Of Medicine · U19 · FY2025 · AI

Structural basis for the functions of dopamine receptors, neurotransmitter transporters, and sigma 1 receptor

$2,478,864
Lei Shi · National Institute On Drug Abuse · ZIA · FY2023 · DA

Chemical Biology Platforms to Define the Metabolism-Epigenetics Interface

$2,478,596
Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Federated Deep Learning to Accelerate Alzheimer's Disease Research

$2,477,877
Paul M Thompson · University Of Southern California · RF1 · FY2025 · AG

Pharmaceutical Research Center

$2,477,561
Henry Lewis · Florida Agricultural And Mechanical Univ · G12 · FY2008 · RR

Chemical Countermeasures Collaboration: Chemical Threats Affecting the Skin, Eyes, and Mucous Membranes

$2,473,664
Office Of The Director, National Institutes Of Health · Y01 · FY2023 · OD

Contraceptive Discovery, Development and Behavioral Research Center

$2,473,290
Gunda I. Georg · University Of Minnesota · U54 · FY2017 · HD